Virus News and Research

Latest Virus News and Research

Fatness drives inactivity, not the other way around

According to a recent longitudinal study in children, inactivity does not lead to fatness! Moreover, the authors concluded that fatness is driving inactivity, and not the other way around. The authors noted that this "reverse causality" explains the observed association between inactivity and fatness. It also explains the repeated failures of the attempts to reduce childhood obesity by increasing physical activity. The study was published in the Archives of Disease in Childhood by Dr. Brad Metcalf and colleagues from Plymouth, UK.

15 Jul 2010

NIH awards MacroGenics $9.8 million grant for three projects

MacroGenics, Inc, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that the National Institutes of Health (NIH) has awarded the company three new grants representing total funding of $9.8 million.

15 Jul 2010

New drug launches for HCV in the Philippines to increase market earned revenues to $4.5 billion by 2017

Efforts to raise disease awareness in the Philippines have increased the number of cases and patient pool available for hepatitis C treatment. Screening and detection efforts by the Red Cross as well as growing awareness in the Philippines have been largely responsible for the rise in the number of diagnosed cases. These campaigns have encouraged people, mostly from the urban areas, to opt for physical examinations that enable the detection of hepatitis C.

15 Jul 2010

Biomagnetics Diagnostics reports positive test results of unique PVA film formulation

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the results of recent testing of the unique PVA film formulation produced by Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. Earlier this week, Biomagnetics announced its intent to acquire Lanzhou as the first of several planned acquisitions to be done at a $1.00 share price valuation for Biomagnetics Diagnostics' common shares.

15 Jul 2010

First 1M doses of smallpox vaccine for immune-compromised populations delivered

Delivery to the Strategic National Stockpile of the first 1 million doses of the nation's first smallpox vaccine for certain immune-compromised populations is now complete, the result of a Project BioShield contract.

15 Jul 2010

Cervical cancer vaccine could reduce number of cases from 3,000 to less than 700 every year

The cervical cancer vaccine could prevent even more cases of the disease in England than previously thought, UK scientists have found.

15 Jul 2010

Pennsylvanians should take steps to reduce exposure to mosquitoes, Secretary of Health advises

The Pennsylvania Department of Health reminds Pennsylvanians to take precautions to reduce exposure to mosquitoes as the season arrives for West Nile virus, or WNV, infections.

15 Jul 2010

Hendra virus treatment to be ready in a few months

Of the dozen people who were exposed to a horse infected with the Hendra virus, 11 have been cleared of the infection by repeated tests on Queensland's Sunshine Coast. These 12 people had first come into contact with the infected horse at Tewantin in May and have since then been subjected to testing to rule out infection with the deadly virus. It is expected that the 12th person will also be cleared soon. Quarantine restrictions were also lifted last month.

14 Jul 2010

First Edition: July 14, 2010

Today's headlines reflect coverage of new federal rules related to "meaningful use" of electronic health records as well as the latest on the federal deficit, the White House's new HIV/AIDS strategy and other developments.

14 Jul 2010

Health Canada approves FluMist for preventing seasonal influenza

AstraZeneca Canada Inc. announced today that Health Canada has approved FluMist (Influenza Vaccine, Live, Attenuated) for the prevention of seasonal influenza. FluMist is the first vaccine in Canada that is administered as a gentle mist sprayed into the nose.

14 Jul 2010

Presidio Pharmaceuticals completes Phase 1a clinical trial of PPI-461 in healthy subjects

Presidio Pharmaceuticals, Inc. announced today the successful completion of a Phase 1a clinical trial of PPI-461, its lead HCV NS5A inhibitor, in healthy subjects. This first-in-human trial evaluated four single doses of PPI-461, followed by a five-day, once-a-day treatment regimen with PPI-461 at the highest tested dose.

14 Jul 2010

Report urges multi-disciplinary research approach to help HIV-positive women stay healthy

A report issued by the Program on International Health and Human Rights at the Harvard School of Public Health proposes a new research agenda to address the sexual and reproductive health and rights of HIV-positive women.

14 Jul 2010

Scientists discover three human antibodies that neutralize HIV

Scientists have discovered three previously unknown human antibodies that neutralize HIV, two of which target a broad range of HIV strains. The findings, reported online July 8 in two Science papers, add a level of encouragement to the AIDS vaccine research field.

14 Jul 2010

IAS announces recipients of CNIHR grants

The International AIDS Society today announced the recipients of its first joint research grant programme, Creative and Novel Ideas in HIV Research. CNIHR grants, funded in partnership with the U.S. National Institutes of Health and the NIH-supported Centers for AIDS Research are designed to promote innovative research and new ideas from early stage investigators whose primary focus has previously been in fields of scientific inquiry other than HIV/ AIDS.

14 Jul 2010

U.N. report released ahead of International AIDS Conference: HIV prevalence drops among young Africans

The number of new HIV infections among young people in Africa is falling in most of the "25 countries hardest hit by the virus," according to a report released Tuesday by UNAIDS, the Associated Press reports (Cheng, 7/13).

14 Jul 2010

Administration to unveil first national HIV/AIDS strategy today

The White House will unveil the first formal national HIV/AIDS strategy on Tuesday, a plan that aims to reduce the number of new cases by 25 percent in the next five years, officials said. Noting that the number of new infections in the United States has been static -- and that the number of people living with HIV is growing -- the new policy would direct more resources toward African Americans and gay and bisexual men. Latinos and substance abusers should also be a priority, the report says.

14 Jul 2010

Opinions: Haitian rebuilding; Nuclear state vaccine initiatives; HIV rights abuses in China; HIV vaccine

The "paltry scale of the Pentagon's reconstruction endeavor [in Haiti] -- 1.6 million people displaced and the American military is contributing a few classrooms? -- is emblematic of the international response," columnist Dana Milbank writes in a Washington Post opinion piece.

14 Jul 2010

Today's OpEds: The Berwick backlash; HIV screening a part of routine care; And why Congress should provide Medicaid help to states

As is well-known, Congress has a constitutional duty to examine presidential nominees like Dr. Berwick. But apparently, the prospect of giving the American people an opportunity to hear this nominee defend his past praise for government-run systems that ration healthcare was worrisome enough for the administration that it sought to ignore congressional oversight altogether (Sen. Mitch McConnell, 7/12).

14 Jul 2010

First Edition: July 13, 2010

Today's health policy headlines include a report about state preparations to cut Medicaid spending as the federal funding stalemate continues and a status check on the start up of high-risk pools.

13 Jul 2010

ABL signs international distribution agreement for Virco BVBA's HIV resistance interpretation system

Advanced Biological Laboratories (ABL) is pleased to announce its recent signature of a non-exclusive international distribution agreement (excluding United States, Australia, Canada and United Kingdom) of virco®TYPE HIV-1, Belgium-based Virco BVBA's HIV resistance interpretation system.

13 Jul 2010

Virus News and Research

Latest Virus News and Research

Fatness drives inactivity, not the other way around

NIH awards MacroGenics $9.8 million grant for three projects

New drug launches for HCV in the Philippines to increase market earned revenues to $4.5 billion by 2017

Biomagnetics Diagnostics reports positive test results of unique PVA film formulation

First 1M doses of smallpox vaccine for immune-compromised populations delivered

Cervical cancer vaccine could reduce number of cases from 3,000 to less than 700 every year

Pennsylvanians should take steps to reduce exposure to mosquitoes, Secretary of Health advises

Hendra virus treatment to be ready in a few months

First Edition: July 14, 2010

Health Canada approves FluMist for preventing seasonal influenza

Presidio Pharmaceuticals completes Phase 1a clinical trial of PPI-461 in healthy subjects

Report urges multi-disciplinary research approach to help HIV-positive women stay healthy

Scientists discover three human antibodies that neutralize HIV

IAS announces recipients of CNIHR grants

U.N. report released ahead of International AIDS Conference: HIV prevalence drops among young Africans

Administration to unveil first national HIV/AIDS strategy today

Opinions: Haitian rebuilding; Nuclear state vaccine initiatives; HIV rights abuses in China; HIV vaccine

Today's OpEds: The Berwick backlash; HIV screening a part of routine care; And why Congress should provide Medicaid help to states

First Edition: July 13, 2010

ABL signs international distribution agreement for Virco BVBA's HIV resistance interpretation system

A new way of characterising biomolecules eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in